Vicinity Energy Steams Ahead to Sustainable Future with Arrival of 42MW Electric Boiler in Cambridge, Mass. Cambridge, Business
Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders USA - English USA - English Cambridge, Business
A Winter Solstice "Third Thursdays" feat. art/dance/poetry/music curated by harmolodic jazz scholar & practitioner Matt Lavelle Cambridge
Alnylam Presents Positive Results from the KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development for the Treatment of Hypertension in Patients at High Cardiovascular Risk Cambridge, Business
National Black Pre-Law Conference and Law Fair Connects Aspiring Black Lawyers to Insider Knowledge, Networking, and Resources Cambridge, Education
Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST Cambridge, Business
Foundation Medicine Announces Participation in National Cancer Institute's ComboMATCH Initiative to Connect Patients with New Anti-Cancer Drug Combinations Cambridge, Business
Gestalt and Pramana Announce Availability of Integrated Digital Pathology Solutions and AI-Powered Platform Cambridge, Business
James Blood Ulmer, one of the "greatest guitarists of all time," followed by a 2nd set feat. D. Bryant, N. Leonard, F. Williams, J. K. Jones Cambridge
New Research from Foundation Medicine and Roche Demonstrates Improved Outcomes Following Treatment Based on Comprehensive Genomic Profiling in Patients with Cancer of Unknown Primary Origin (CUP) Cambridge, Business
Alaya.bio Acquires Key Assets From Ixaka France, Accelerating the Progress of Its Novel In Vivo CAR-T Immunotherapy Platform Cambridge, Business
Harmolodic jazzer Dave Bryant announces his Fall "Third Thursdays" lineup, incl. James Blood Ulmer Cambridge
Ankyra Therapeutics Presents Preliminary Phase 1 Canine Clinical Data Evaluating cANK-101 to Treat Advanced Malignant Melanoma in Dogs Cambridge, Business
Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders Cambridge, Business
n-Lorem Foundation Convenes First Annual Nano-rare Patient Colloquium to Share Accomplishments and Learnings in Developing Optimized ASO Therapies for Nano-rare Patients Cambridge, Business
ARTBIO Announces Appointment of Nick Pullen, Ph.D., as Chief Scientific Officer USA - English USA - English Cambridge, Business
Thymmune Therapeutics Receives $37M in Funding from the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H) Cambridge, Business